No Data
No Data
Hong Kong Stock Announcement Gold Mining | SITC's annual profit attributable to shareholders is 1.028 billion US dollars, representing a year-on-year increase of 93.51%.
SINO BIOPHARM (01177): Global first JAK/ROCK inhibitor "Rovadicitinib" phase IB/IIA clinical research results published in "Blood"; SITC's annual shareholder attributable profit of 1.028 billion USD, a year-on-year increase of 93.51%...
SITC International Holdings Logs Higher Profit for 2024; EPS, Revenue Exceed Estimates; Shares Up 8%
SITC International Declares Final Dividend for 2024
SITC (01308.HK) reported a profit increase of 92.9% to 1.0343 billion USD for the fiscal year 2024, with a final dividend of 1.4 HKD per share.
On March 10, Gelonghui announced that SITC (01308.HK) published its annual performance report. For the fiscal year ending December 31, 2024, revenue was approximately 3.0581 billion USD, an increase of about 25.9% year-on-year. Gross profit was approximately 1.1428 billion USD, a year-on-year increase of about 83.4%, with the gross margin rising from approximately 25.7% in the same period to about 37.4%; annual profit was approximately 1.0343 billion USD, a year-on-year increase of about 92.9%, with basic earnings per share of 0.39 USD, and a proposed final dividend of 1.40 HKD per share. The increase in revenue was due to (i) container throughput from 3 in 2023.
Express News | SITC International Holdings FY Gross Profit USD 1,142.8 Million
Express News | SITC International Holdings FY Basic EPS USD 0.39